Total Funding
5
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2090303
X-BODY is a biotechnology company that discovers and develops compounds against targets in oncology and ophthalmology.
Acquired by 
Juno Therapeutics
Brant Binder: Co-Founder and Director
About the Company
X-BODY is a biotechnology company that discovers and develops compounds against targets in oncology and ophthalmology.
The company's mission is to apply its innovative capabilities to the discovery of human antibodies against high-value therapeutic targets. X-BODY has entered into a number of alliances with other corporations to generate
antibody therapeutic candidates. X-BODY's internal efforts are focused on discovering and developing compounds against biologically relevant targets in oncology and ophthalmology.
X-BODY was formed in 2008 by industry veterans Richard Wagner, Brant Binder, and Gordon Binder.
